Talk Title:Design of a phase 2 first-in-ADPKD clinical trial of the Sodium/Glucose Cotransporter-2 inhibitor (SGLT2i) empagliflozin
https://www.pkd-rrc.org/wp-content/uploads/2021/04/PKDRRC_Logo_final-300x141.png00Academic Web Pageshttps://www.pkd-rrc.org/wp-content/uploads/2021/04/PKDRRC_Logo_final-300x141.pngAcademic Web Pages2023-11-02 16:15:472023-11-13 13:36:55PKD RRC Monthly Scientific Roundtable Speaker for December 4, 2023, will be Stephen Seliger, M.D., M.S., University of Maryland School of Medicine
